NGNE
#2677
Neurogene Inc. - Common Stock
36.5 8 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.38%
Variación mensual
+8.71%
Variación en los últimos 6 meses
+55.99%
Cambio anual
+24.34%
Cierres anteriores
37.8 6
Open
36.5 8
Mínimo
36.5 8
Máximo
36.5 8
Volumen
32
Financials
- Market Capitalization 732.02 M
- Employee 131
- Founded 2018
- CEO Jonathan Drachman M.D.
- Website www.neurogene.com
- Headquarter New York, United States
- FIGI BBG005Y0QDK1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.86
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2667 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.18 USD | +2.68% | +3.38% | +3.15% | -23.37% | 742.67 M USD | ||
| 2674 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.59 USD | -1.35% | -4.35% | +15.21% | -20.22% | 734.85 M USD | ||
| 2697 |  STTK Shattuck Labs, Inc. - Common Stock | 7.04 USD | -7.97% | -8.09% | +2.77% | +611.11% | 706.56 M USD | ||
| 2703 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.74 USD | -4.79% | -0.91% | +5.68% | -3.10% | 700.72 M USD |